|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
¶ – Release Delayed to: 6/28/18 ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 5/14/18 Bionano Genomics, Inc DRS¶ 6/28/18 39:8.9M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: DRS Draft Registration Statement by an Emerging Growth HTML 1.22M
Company or a Foreign Private Issuer
2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 151K
3: EX-3.3 Articles of Incorporation/Organization or By-Laws HTML 87K
4: EX-4.2 Instrument Defining the Rights of Security Holders HTML 41K
5: EX-4.3 Instrument Defining the Rights of Security Holders HTML 41K
6: EX-4.4 Instrument Defining the Rights of Security Holders HTML 58K
7: EX-4.5 Instrument Defining the Rights of Security Holders HTML 49K
8: EX-4.6 Instrument Defining the Rights of Security Holders HTML 57K
9: EX-4.7 Instrument Defining the Rights of Security Holders HTML 49K
10: EX-10.1 Material Contract HTML 145K
13: EX-10.10 Material Contract HTML 119K
14: EX-10.11 Material Contract HTML 93K
15: EX-10.12 Material Contract HTML 79K
16: EX-10.13 Material Contract HTML 73K
17: EX-10.14 Material Contract HTML 75K
18: EX-10.15 Material Contract HTML 230K
19: EX-10.16 Material Contract HTML 113K
20: EX-10.17 Material Contract HTML 20K
21: EX-10.18 Material Contract HTML 280K
22: EX-10.19 Material Contract HTML 68K
11: EX-10.2 Material Contract HTML 71K
23: EX-10.20 Material Contract HTML 259K
24: EX-10.21 Material Contract HTML 27K
25: EX-10.22 Material Contract HTML 84K
26: EX-10.23 Material Contract HTML 532K
27: EX-10.24 Material Contract HTML 99K
28: EX-10.25 Material Contract HTML 110K
29: EX-10.26 Material Contract HTML 17K
30: EX-10.27 Material Contract HTML 22K
31: EX-10.28 Material Contract HTML 17K
32: EX-10.29 Material Contract HTML 16K
12: EX-10.3 Material Contract HTML 58K
33: EX-10.30 Material Contract HTML 152K
34: EX-10.31 Material Contract HTML 80K
35: EX-10.32 Material Contract HTML 60K
36: EX-10.33 Material Contract HTML 34K
37: EX-10.34 Material Contract HTML 61K
38: EX-10.35 Material Contract HTML 65K
39: EX-21.1 Subsidiaries HTML 11K
| EX-10.29 |
Exhibit 10.29
***Text Omitted and Filed Separately
with the Securities and Exchange Commission
Confidential Treatment Requested
Under 17 C.F.R. Sections 200.80(b)(4)
and 230.406
Fourth Amendment to License Agreement
AMENDMENT dated as of February 9th, 2012, to the License Agreement (“Agreement”) with an Effective Date of January 7th, 2004 between PRINCETON UNIVERSITY, a not-for- profit corporation duly organized and existing under the laws of the State of New Jersey and having a principal place of business at 4 New South Building, Princeton, New Jersey 08544-0036, United States of America, (“PRINCETON”) and BIONANO GENOMICS, INC., a corporation duly organized and existing under the laws of the State of Delaware (hereinafter referred to as “BioNano Genomics”).
WITNESSETH
WHEREAS, the Parties have entered into the Agreement and would like to amend the Agreement;
WHEREAS, the Parties now seek to amend the terms of the Agreement as set forth herein.
NOW THEREFORE, in consideration of the premises and the mutual covenants contained herein, the Parties agree to as follows:
| 1. | Section 5.4(g) shall be shall be deleted in its entirety and replaced with the following language: |
BioNano Genomics shall achieve total sales of […***…] of at least […***…] during the […***…].
| BIONANO GENOMICS, INC. | PRINCETON UNIVERSITY | |||||||
| Signature: | /s/ R. Erik Holmlin | Signature: | /s/ John F. Ritter | |||||
| Name: | R. Erik Holmlin | Name: | John F. Ritter, Director | |||||
| Title: | CEO | Title: | Office of Technology Licensing and Intellectual Property | |||||
| Date: | Feb 10, 2012 | Date: | 2/9/12 | |||||
***Confidential Treatment Requested
1.
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/08/18 SEC UPLOAD¶ 9/18/18 1:159K Bionano Genomics, Inc. |